TMO
Thermo Fisher Scientific
$226.93Bn
613.75
-0.75%
+25.39%
The company's Life Sciences Solutions and Analytical Instruments segments provide a vast portfolio of reagents, instruments, and consumables for biological and medical research, genomic and proteomic analysis, and electron microscopy. These products are sold to universities, research institutions, and biotech firms to support scientific research and bioproduction.
DHR
Danaher
$145.94Bn
207.62
-1.60%
+4.32%
Danaher's Life Sciences and Biotechnology segments provide instruments, consumables, and software for bioprocessing, genomics, and proteomics used in laboratory research and biopharmaceutical manufacturing. These products are sold to research institutions and biotech companies to study biological molecules like DNA and RNA.
BDX
2nd
Becton Dickinson
$50.32Bn
184.73
-1.55%
-3.41%
BD sells research and clinical tools for the study of cells, including fluorescence-activated cell sorters, analyzers, and reagents for life science research.
A
Agilent Technologies
$42.55Bn
150.90
+0.65%
+20.51%
Agilent designs and manufactures life-sciences research tools and instruments, including liquid chromatography, gas chromatography, and mass spectrometry systems. These products are sold to pharmaceutical, biotechnology, and academic research institutions for drug discovery and chemical analysis.
IDXX
2nd
Idexx Laboratories
$42.23Bn
535.38
+1.15%
-16.40%
Idexx sells health monitoring and biological materials testing products specifically for biomedical research customers and research institutions.
WAT
Waters
$40.23Bn
409.52
-1.01%
+36.65%
Waters Corporation designs and manufactures analytical instruments, including HPLC, UPLC, and mass spectrometry systems, as well as chromatography columns and reagents. These products are sold as tools for life-sciences research and bioproduction to customers in pharmaceuticals, biotechnology, and academic research.
ILMN
Illumina
$32.95Bn
218.22
-1.55%
+127.15%
Illumina designs and manufactures sequencing and array-based instruments, reagents, and library preparation kits used for genomics and proteomics research. Its primary revenue comes from selling these life-sciences research tools and consumables to research institutions, academic centers, and biotechnology companies.
IR
2nd
Ingersoll Rand
$29.62Bn
76.34
+1.25%
-3.61%
The Precision and Science Technologies segment designs and manufactures life science tools and single-use powder and liquid handling containment solutions for life science and medical applications.
MTD
2nd
Mettler Toledo International
$29.15Bn
1,344.10
-0.89%
+5.95%
Mettler-Toledo designs and manufactures laboratory instruments, including balances, pipettes, and analyzers, which contribute approximately 56% of net sales and are used in life sciences research and development.
STE
2nd
Steris
$21.90Bn
224.63
-0.83%
-7.71%
The Life Sciences segment provides pharmaceutical detergents, cleanroom disinfectants, and research sterilizers specifically for biopharmaceutical and medical device manufacturing facilities.
RVTY
Revvity
$14.53Bn
130.24
-0.28%
+56.24%
Revvity's Life Sciences segment sells a comprehensive portfolio of research tools, including radiometric detection reagents, microscopy imaging reagents, recombinant cell lines, and automated liquid handling platforms to pharmaceutical, biotech, and academic researchers.
CRL
2nd
Charles River Laboratories International
$13.77Bn
288.60
-1.56%
+77.79%
The Research Models and Services segment supplies purpose-bred rodents, large research models, and cell solutions used by clients for drug discovery and development activities.
TECH
Bio-Techne
$11.31Bn
72.43
-0.03%
+36.87%
Bio-Techne's Protein Sciences segment sells high-quality biological reagents such as cytokines, growth factors, and antibodies, as well as proteomic analytical tools like western blot systems and multiplexed ELISA platforms for life science research and drug discovery.
DCI
2nd
Donaldson
$10.55Bn
91.03
+0.56%
+14.33%
The Life Sciences segment sells bioprocessing equipment such as bioreactors and fermenters, as well as consumables including chromatography devices and reagents used for cell growth, separation, and purification.
BIO
Bio-Rad Laboratories
$10.34Bn
386.54
-0.34%
+34.19%
Bio-Rad's Life Science segment develops and markets instruments, systems, reagents, and consumables used to separate, purify, and quantify biological materials for research and biopharmaceutical manufacturing. These products are sold to universities, medical schools, and biotechnology companies for use in laboratory environments.
RGEN
Repligen
$9.46Bn
167.60
-1.19%
+38.99%
Repligen provides bioprocessing technologies, instruments, and consumables used in the manufacturing of biological drugs, such as XCell ATF cell retention systems and OPUS PrePacked Columns. Its revenue is generated from the sale of these life-sciences research and bioproduction tools to biopharmaceutical companies and CDMOs.
BRKR
Bruker
$8.91Bn
58.50
-1.53%
+96.37%
Bruker's core business is the development and manufacture of high-performance scientific instruments for life sciences research, including mass spectrometry (timsTOF), nuclear magnetic resonance (NMR) systems, and spatial biology platforms (CosMx). These tools are sold to academic, government, pharmaceutical, and biotechnology customers for molecular and cellular research.
TXG
10x Genomics
$8.16Bn
62.65
-0.90%
+361.68%
10x Genomics develops and sells instruments and consumables for life-sciences research, specifically the Chromium single cell platform and Visium and Xenium spatial platforms. Its customers include academic research institutions, government laboratories, and biotechnology firms using these tools for biological analysis.
TWST
Twist Bioscience
$7.82Bn
124.72
-3.10%
+379.69%
Twist Bioscience manufactures and sells synthetic genes, oligonucleotides, and next-generation sequencing tools (such as target enrichment probes and library preparation kits) used for research and bioproduction. These products are sold to biotech, pharma, and academic laboratories for applications like drug discovery and basic biological investigation.
GRFS
2nd
Grifols
$5.31Bn
7.80
-1.02%
-18.67%
Through its Bio Supplies segment, the company sells biological materials, cell culture media, and stem cell reagents to biotechnology companies and academic institutions for research and manufacturing.
GRAL
2nd
Grail
$3.59Bn
80.34
-0.35%
+147.81%
GRAIL generates income from 'research use only' offerings and collaborations with biopharmaceutical partners for biomarker discovery and minimal residual disease monitoring.
PGEN
2nd
Precigen
$2.54Bn
7.10
-0.56%
+49.47%
Through its Exemplar subsidiary, the company sells genetically engineered porcine research models to academic and industry customers for use in drug discovery and preclinical studies.
NKTR
2nd
Nektar Therapeutics
$2.45Bn
74.19
-2.85%
+106.20%
The company historically generated revenue from the sale of its proprietary polyethylene glycol (PEG) reagents, which are tools used in bioproduction and life-sciences research to enhance drug pharmacokinetics.
MRVI
Maravai Lifesciences Holdings
$1.90Bn
7.32
-0.68%
+210.17%
Maravai sells complex nucleic acids, custom enzymes, and antibody-based solutions used for research and biopharmaceutical production. These products, including mRNA oligonucleotides and nucleoside triphosphates, are sold to biopharmaceutical companies, biotech firms, and academic research institutions as life-sciences research tools and bioprocessing supplies.
BLFS
Biolife Solutions
$1.72Bn
35.25
-0.79%
+36.26%
Biolife Solutions provides tools, reagents, and consumables for bioproduction and life-sciences research, specifically biopreservation media like HypoThermosol® FRS and CryoStor® Freeze Media. Its customers include academic research institutions and biopharma manufacturers using these tools for basic and applied research.
AZTA
Azenta
$1.37Bn
31.33
+0.48%
+6.67%
Azenta sells a broad portfolio of life sciences research tools, including automated storage systems, cryogenic systems, and consumables like racks, tubes, and plates. These products are sold to pharmaceutical, biotechnology, and academic research institutions for sample exploration and management.
CYRX
2nd
Cryoport
$800.75Mn
15.81
-0.32%
+86.00%
Cryoport provides bioprocessing and research-related tools through its IntegriCell cryopreservation services and BioStorage solutions used for preclinical and early-stage clinical materials.
MLAB
Mesa Laboratories
$715.03Mn
127.78
-0.58%
+98.63%
Mesa Laboratories designs and manufactures life sciences tools, including the MassARRAY system for genomic testing and Gyrolab systems for protein analysis and peptide synthesis. These products, along with their associated chips, panels, and reagents, are sold to biopharma R&D teams, academic laboratories, and clinical research labs.
OABI
2nd
OmniAb
$629.54Mn
4.33
-8.84%
+170.62%
Through its xPloration segment, the company sells instruments and related consumables used in antibody discovery and optimization workflows to external customers.
CTKB
Cytek Biosciences
$610.92Mn
4.70
+0.00%
+19.29%
Cytek Biosciences develops and sells flow cytometry instruments, such as the Aurora and Northern Lights systems, and reagents like cFluor and Tonbo for high-dimensional single cell analysis. Its primary customers are pharmaceutical companies, biopharma firms, and academic research centers using these tools for drug discovery and research in oncology and immunology.
DNA
2nd
Ginkgo Bioworks Holdings
$442.79Mn
6.95
+0.00%
-38.66%
The company sells standardized tools and data assets, such as RAC systems and Datapoints, which are used for life-sciences research and bioproduction.
PACB
Pacific Biosciences Of California
$419.59Mn
1.35
+3.85%
+8.87%
Pacific Biosciences designs and manufactures sequencing instruments such as the Revio, Vega, and Sequel platforms, as well as proprietary consumables like SMRT cells and reagent kits. These products are sold to academic, governmental, and commercial research institutions for life-sciences research and genomic analysis.
MASS
2nd
908 Devices
$382.49Mn
10.05
+0.10%
+82.07%
The company sells its handheld chemical analysis devices to life science researchers for laboratory and field work, providing tools for research and bioproduction analysis.
TKNO
Alpha Teknova
$371.48Mn
6.92
-4.42%
+62.82%
Alpha Teknova manufactures and sells reagents, pre-poured media plates, and liquid microbial culture media used for life-sciences research and bioproduction. Its Lab Essentials segment, which contributes 76.6% of revenue, specifically provides RUO formulations for applications like next generation sequencing and spatial biology.
LAB
Standard Biotools
$270.56Mn
0.69
+2.99%
-46.51%
Standard BioTools develops and sells instrumentation, consumables, and reagents for proteomics and genomics research, specifically through its CyTOF, Hyperion, and Biomark platforms. Its customers are research institutions and biopharmaceutical companies, and the profile explicitly states its products are marketed for research use only and not for clinical diagnostics.
OSUR
2nd
Orasure Technologies
$244.96Mn
3.48
-2.79%
+10.83%
The Sample Management Solutions segment sells tools, reagents, and consumables such as Oragene and ORAcollect kits for genomics, proteomics, and microbiome research to academic labs and biotech companies.
SEER
Seer
$216.21Mn
1.95
+0.52%
-2.99%
Seer sells the Proteograph Product Suite, which consists of life-sciences research tools including the SP200 automation instrument and consumable assays (Proteograph ONE and DIRECT) used for deep proteomic analysis. These products are sold to academic institutions and biopharmaceutical companies for basic research and biomarker discovery.
LFCR
2nd
Lifecore Biomedical
$162.92Mn
4.40
+1.15%
-44.58%
The company manufactures and sells pharmaceutical grade non-animal sourced hyaluronic acid (HA) in bulk form as a raw material for customers' use in various medical applications.
QSI
Quantum-Si
$153.19Mn
0.77
+1.32%
-28.04%
Quantum-Si sells the Platinum and Platinum Pro protein sequencers, as well as consumable kits (Library Preparation, Barcoding, and Sequencing Kits), which are tools and reagents used for life-sciences research in proteomics. Its customers include academic research institutions, biopharmaceutical companies, and industrial laboratories using the platform for biomarker discovery and vaccine development.
MXCT
Maxcyte
$135.85Mn
1.28
+1.59%
-5.88%
MaxCyte sells the ExPERT family of instruments, proprietary processing assemblies (PAs), and consumables like electroporation buffers used for cell engineering and bioproduction. These products are sold to biopharmaceutical companies, academic institutions, and government research organizations for life-sciences research and development.
CDXS
Codexis
$133.43Mn
1.46
+2.82%
-39.42%
Codexis sells engineered enzymes and proteins as biocatalysts and provides the CodeEvolver technology platform for bioproduction. Its revenue is derived from the sale of these research and production tools to pharmaceutical and biotechnology firms.
QTRX
Quanterix
$126.79Mn
2.69
+4.26%
-38.16%
Quanterix primarily sells life-sciences research tools, including the Simoa and Spatial Biology instruments (HD-X, SR-X, SP-X, PhenoCycler), as well as the associated assay kits, consumables, and reagents used by academic research labs and biopharmaceutical firms.
NAUT
Nautilus Biotechnology
$114.50Mn
0.90
-2.17%
+38.08%
Nautilus Biotechnology develops the Nautilus Voyager system, which is a life-sciences research tool for single molecule protein analysis. The company targets academic, biopharmaceutical, and research institutions for drug discovery and basic biology, selling instruments and recurring consumables like flow cells and reagent kits.
ALPS
Alps
$63.23Mn
0.38
+0.00%
—
Alps Life Sciences Inc is engaged in the research, development, and commercialization of life sciences products and services, serving research institutions, laboratories, and biotechnology firms. This aligns with the provision of tools and reagents for life-sciences research and bioproduction.
RPID
2nd
Rapid Micro Biosystems
$59.56Mn
1.31
-5.07%
-46.31%
The company provides automation solutions and tools for microbial quality control used in pharmaceutical manufacturing and bioproduction. Its systems are used by manufacturers of cell and gene therapies to ensure product quality during the production process.
JANL
2nd
Janel
$59.32Mn
50.00
+0.00%
+25.00%
The Life Sciences segment manufactures and distributes antibodies and research and diagnostic reagents for academic, non-profit, and commercial customers, which are tools used for life-sciences research.
IMMP
2nd
Immutep
$52.57Mn
0.36
-2.70%
-77.91%
The company generates income through its subsidiary, Immutep S A S, which manufactures and distributes research reagents to scientists via third-party distributors such as Adipogen and Enzo.
SGMOQ
2nd
Sangamo Therapeutics
$44.83Mn
0.16
-5.88%
-69.81%
The company explicitly expects to receive additional income from licensing its technology to other industries, specifically mentioning research reagents.
HBIO
Harvard Bioscience
$36.51Mn
8.02
+0.25%
+70.64%
Harvard Bioscience develops and manufactures instruments, reagents, and consumables for life-sciences research, such as spectrophotometers, amino acid analyzers, and electroporation systems. Its products are sold to academic institutions and pharmaceutical companies for use in early discovery and bioproduction.
VRXA
2nd
Veraxa Biotech AG - Post de-SPAC
$25.48Mn
1.76
+15.03%
-83.11%
The company operates the Hitmaster Microfluidics Platform, which provides high-throughput antibody discovery, single-cell analysis, and precision sorting of biological particles for research and diagnostic applications.
DYAI
2nd
Dyadic International
$18.95Mn
0.52
+4.00%
-46.94%
The company sells life science reagents such as albumin, transferrin, and DNase I, and serves life science researchers and diagnostic manufacturers.
BNGO
Bionano Genomics
$14.13Mn
1.20
-3.23%
-69.07%
Bionano Genomics sells optical genome mapping instruments like the Saphyr and Stratys systems, along with the consumables and reagents required to operate them. These products are sold to academic research institutions and biotechnology companies for life-sciences research and genomic analysis.
ADVB
2nd
Advanced Biomed
$12.91Mn
9.34
-0.64%
+3.78%
The company targets research institutions with its microfluidic technology platforms and related products for oncology detection.
SCND
Scientific Industries
$9.54Mn
0.80
+0.00%
+6.67%
Scientific Industries designs and manufactures benchtop laboratory equipment and bioprocessing systems, such as biomass monitoring sensors and moisture analyzers, sold to universities and pharmaceutical companies for research. These products, including the DOTS brand platform and Torbal balances, are classic life-sciences research tools and bioprocessing supplies.
CDIO
2nd
Cardio Diagnostics Holdings
$5.50Mn
1.86
+1.64%
-52.19%
The company provides research use only kits under the CardioInnovate360 brand specifically to support biopharmaceutical development.
POAS
2nd
Phaos Technology Holdings (Cayman)
$5.05Mn
0.16
+0.00%
—
The company sells the PT-Biology (PT-B) series and other super-resolution imagers to R&D institutions and biomedical service providers for research and innovation activities. These products serve as life-sciences research tools for observing details beyond the conventional optical limit.
CLGN
2nd
CollPlant Biotechnologies
$4.55Mn
3.55
+944.12%
+36.54%
CollPlant sells bioinks, collagen solutions, and rhCollagen to research institutions, academic laboratories, and STEMCELL Technologies for use in cell culture media kits and life-sciences research.
HCWB
2nd
HCW Biologics
$3.90Mn
2.94
+2.44%
-38.75%
The company commercializes and sells specific reagents, HCW9201 and HCW9206, which are used by partners to improve the manufacturing of CAR T and natural killer cell therapies.
ISCO
2nd
International Stem Cell
$3.36Mn
0.42
+0.00%
+200.00%
Through its Lifeline Cell Technology business, the company sells over two hundred human cell-based items, including primary cells, stem cells, and specialized media, to academic, government, and industrial laboratories.
ISPC
iSpecimen
$2.34Mn
1.54
+0.00%
-94.25%
iSpecimen sells human biospecimens, including biofluids, tissues, and living cells, to life science researchers for use in discovery and development. These products are essential reagents and materials for life-sciences research, fitting the description of tools and consumables for bioproduction and research.
NUMD
2nd
Nu-Med Plus
$1.67Mn
0.02
+0.00%
-33.33%
The company offers a 'Research Dilution System' specifically designed for investigational applications in laboratory settings and research institutions to produce high-purity nitric oxide for biomedical research.
BJDX
2nd
Bluejay Diagnostics
$1.65Mn
0.83
-2.35%
-85.79%
The company is evaluating opportunities to place its analyzers for research use only (RUO) purposes in laboratories and academic institutions, which falls under life-sciences research tools.
VNRX
2nd
Volitionrx
$1.39Mn
0.34
+0.00%
-97.32%
The company sells Capture-Seq™/Capture-PCR™ kits and components to research partners and provides nucleosome profiling services via Nu. Q® Discover for drug developers and scientists.
BNBX
Bnb Plus
$1.17Mn
0.14
+0.00%
-95.22%
The company's primary revenue is generated through LineaRx, which sells synthetic DNA templates, RNA production enzymes, and mRNA manufacturing kits to biotechnology firms and research institutions. These products are tools and reagents used for life-sciences research and bioproduction.
NOTVQ
2nd
Inotiv
$348.88K
0.01
+0.00%
-99.55%
Through its Research Models and Services (RMS) segment, the company sells research-quality animals, specialized disease models, and Teklad brand laboratory animal diet and bedding to academia, government clients, and pharmaceutical companies.